UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): July 20, 2004
Commission File No. 0-11178
-------
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
UTAH 87-0342734
------------------------------- ------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
Registrant's telephone number: (801) 566-1200
--------------
-------------------------------------------------------------------------------
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
-------------------------------------------------------------------------------
Attached hereto as Exhibit 99.1 and incorporated by reference herein is
financial information for Utah Medical Products, Inc. for the quarter ended June
30, 2004 and forward-looking statements relating to 2004 and beyond as presented
in a press release dated July 20, 2004. The information in this report shall be
deemed incorporated by reference into any registration statement heretofore or
hereafter filed under the Securities Act of 1933, as amended, except to the
extent that such information is superseded by information as of a subsequent
date that is included in or incorporated by reference into such registration
statement. The information in this report shall not be treated as filed for
purposes of the Securities Exchange Act of 1934, as amended.
--------------------------------------------------------------------------------
SIGNATURES
--------------------------------------------------------------------------------
Pursuant to the requirements of the Securities Exchanges Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
UTAH MEDICAL PRODUCTS, INC.
---------------------------
REGISTRANT
Date: 7/20/2004 By: /s/ Kevin L.Cornwell
------------------------------------- --------------------------
Kevin L. Cornwell
CEO
--------------------------------------------------------------------------------
EXHIBIT INDEX
Index
Number Description
------ -----------
99.1 Financial information for Utah Medical Products, Inc.
for the quarter ended June 30, 2004 and forward-looking
statements relating to 2004 and beyond as presented in a
press release dated July 20, 2004.